1211003", "pub-id_pmid": "18246127", "section_type": "REF", "source": "Oncogene", "type": "ref", "volume": "27", "year": "2008"}, "text": "Mutant B-RAF mediates resistance to anoikis via Bad and Bim", "sentences": [], "annotations": [], "relations": []}, {"offset": 31540, "infons": {"comment": "suppl; abstr 9000", "issue": "15s", "name_0": "surname:Flaherty;given-names:K", "name_1": "surname:Puzanov;given-names:I", "name_2": "surname:Sosman;given-names:J", "name_3": "surname:Kim;given-names:K", "name_4": "surname:Ribas;given-names:A", "name_5": "surname:McArthur;given-names:G", "name_6": "surname:Lee;given-names:RJ", "name_7": "surname:Grippo;given-names:JF", "name_8": "surname:Nolop;given-names:K", "name_9": "surname:Chapman;given-names:P", "pub-id_pmid": "19917835", "section_type": "REF", "source": "J Clin Oncol", "type": "ref", "volume": "27", "year": "2009"}, "text": "Phase I study of PLX4032: proof of concept for V600E BRAF mutation as a therapeutic target in human cancer", "sentences": [], "annotations": [], "relations": []}], "annotations": [], "relations": []}]}]